Briacell Therapeutics

BCTX

Market cap $31.7M

BCTX Hedge Fund Activity: Q1 2026 in Review

16 of the 8,149 institutional investors tracked by Wall St. Rank reported a position in Briacell Therapeutics (BCTX) for Q1 2026, worth a combined $1.62M — up 2,242% from $69.2K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new BCTX positions and 3 closed out — a net gain of 3 holders — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Cable Car Capital, opening a new position worth an estimated $1.01M. The largest seller was Flagship Harbor Advisors, exiting entirely with an estimated $28.4K sold.

• 16 institutional investors held Briacell Therapeutics (BCTX) as of Q1 2026, up from 13 in Q4 2025.
• Funds reported $1.62M of Briacell Therapeutics stock for Q1 2026, up 2,242% quarter-over-quarter.
• 6 funds opened new Briacell Therapeutics positions in Q1 2026 and 3 closed out, a net change of +3 holders.
• The largest Briacell Therapeutics buyer in Q1 2026 was Cable Car Capital, an estimated $1.01M added.
• The largest Briacell Therapeutics seller in Q1 2026 was Flagship Harbor Advisors, an estimated $28.4K sold.

Based on aggregated 13F filings for Q1 2026.